RIGEL PHARMACEUTICALS INC — Director's Dealing 2011

May 21, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2011-05-20

Reporting Person: MOOS WALTER H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-05-20	Stock Option (Right to Buy)	$8.335	A	15000	Acquired	2021-05-20	Common Stock (15000)	Direct

Footnotes

F1: The shares vest monthly for twelve (12) months from the date of grant.